Gillian Ryan joined George Clinical in the spring of 2021 with over 20 years of experience in the pharmaceutical industry including experience working in, and with, large pharma companies and clinical research organizations, across all phases of drug development and many therapeutic areas. Gillian’s experience spans both project operations and medical affairs and she holds a particular passion for the more unique and complex trials such as early phase human and patient clinical trials.

Ryan brings to George Clinical highly developed people management expertise, demonstrated accountability for project delivery, thorough project financial management experience, an understanding of the complex nature of research and an innate love for new medicine. These unique offerings enable her to effectively lead a diverse capable early phase team and to be responsible for the development of strategies to support new business proposals in the early phase research arena.

“Gillian not only brings George Clinical significant early phase management expertise, but also a history of developing and maintaining productive relationships with key opinion leaders, delivering sponsors a trusted advisor in local and international quality and technical standards, and veteran project oversight,” said Chief Medical Officer Maria Ali.

With a deep and well-regarded history conducting early phase studies, George Clinical stands as a leading global clinical research organization driven by scientific expertise and operational excellence. Our teams help move clients through the regulation process to quick start-up and help them think through your early phase trial strategies, site selections and operational models. Using the combination of our scientific expertise and local knowledge, George Clinical managed trials maintain their focus on the scientific objective while maximizing site selection, recruitment, and overall trial efficiencies for the best result possible.